|
More on DM1 from Immunogen
"ImmunoGen's TAP (tumour-activated prodrug) technology uses tumor-targeting antibodies to deliver a highly potent cell-killing agent specifically to cancer cells. ImmunoGen's proprietary DM1 is designed to remain attached to the antibody and inactive while the TAP product is circulating through the bloodstream, yet readily kill cancer cells once the product has reached the tumor."
|
Threaded Mode